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I. Abstract 
 
Protein phosphorylation is a post-translational modification (PTM) that is ubiquitous in 
regulating cellular processes. It is the most common PTM used in signal translation. 
Protein kinases are the class of enzymes that catalyze the transfer of a phosphate 
group from ATP to a specific amino acid on a substrate protein. In eukaryotes, kinases 
generally add a phosphate to serine, threonine, or tyrosine residues. Short linear 
patterns in the amino acid sequence of the substrate protein help guide the protein 
kinase to the correct residue to be phosphorylated. However, these patterns, or 
“motifs,” as well as the complete list of substrates for each kinase are largely 
unknown. A method known as ProPeL (Proteomic Peptide Library) can be utilized to 
discover motifs, and thus potential target substrates, of a protein kinase-of-interest. 
For this project, ProPeL and the visualization tool known as pLogo (Probability Logo 
Generator) have been utilized to examine the specificity motifs of two DYRK family 
protein kinases, DYRK2 and DYRK4. Our preliminary data suggests that the substrate 
specificities for DYRK2 and DYRK4 are similar to the canonical member, DYRK1a; 
however, distinct differences have been found. For example, DYRK2 may have a 
higher stoichiometry of protein phosphorylation at tyrosine sites, and DYRK4 may not 
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exhibit the typical preference for serine over threonine when phosphorylating 
substrates. For both DYRK2 and DYRK4, additional data will need to be collected to 
obtain more statistically significant results. 
II. Introduction 
Protein Phosphorylation 
Post-translational modifications (PTMs) are found on almost every protein and 
these modifications have been found to be fundamental for cellular regulation.1   
Reversible protein phosphorylation is one of the most common PTMs in eukaryotic 
cells.2 Reversible phosphorylation comprises two opposing reactions: phosphorylation 
and dephosphorylation. Phosphorylation is catalyzed by a class of enzymes, called 
protein kinases, and dephosphorylation is catalyzed by a class of enzymes, called 
phosphatases.1,3 Protein kinases and phosphatases can alter the function of a protein in 
a multitude of ways. For example, adding or removing a phosphate group from a protein 
can increase or decrease its biological activity, stabilize or mark the protein for 
degradation, or facilitate or disrupt the formation of protein-protein interactions.4,5    
The mechanism of protein phosphorylation by a protein kinase involves the 
transfer of the γ-phosphate group of ATP to the hydroxyl oxygen of a serine, threonine, 
or tyrosine residue of a substrate (Figure 1).1,5  
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Figure 1. Mechanism of substrate phosphorylation by a protein kinase.
5
 (1) ATP binds to the active 
site of a kinase. (2) The substrate binds to the active site. (3) The gamma-phosphate of ATP is 
transferred to a serine, threonine, or tyrosine residue of the substrate. (4) Following phosphorylation, the 
substrate is released from the kinase. (5) ADP is released from the active site of the kinase. This figure is 
adapted from Ubersax et al. (2007).5!
!
It is estimated that one-third of all of the proteins encoded by the human genome 
are modified by phosphorylation.4,5 Therefore, it is not surprising that protein 
phosphorylation is crucial for regulating numerous cellular processes, such as 
metabolism, cell proliferation, and apoptosis.1,3 Abnormal phosphorylation can also be 
the cause or symptom of many human diseases, such as cancer.6,7  
Protein Kinase Specificity  
Currently, there are over 250,000 annotated phosphorylation sites in mammals 
and every kinase varies greatly in its expression, activity, and function.8 Therefore, there 
must be a mechanism for distinguishing specific substrate(s) among the thousands of 
proteins. It has been determined that most kinases are directed to their substrate, 
commonly through temporal and spatial co-expression and/or protein-protein 
interactions.5 Once a kinase is located near its substrate, short linear patterns or 
2 1 
3 
4 5 
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“motifs” in the primary structure of the substrate guide the catalytic pocket of the kinase 
to the correct residue to be phosphorylated.9 Often, the substrate motif and the 
complementary sequence of the kinase interact through ionic bonding, hydrogen 
bonding, or hydrophobic interactions, which increase the local substrate specificity of 
many kinases. Identifying the specificity motif for a kinase can be a useful first step 
toward pinpointing its downstream target substrates and its overall function in the 
cell.5,9,10,11  
ProPeL Methodology 
In order to determine the specificity motif for a kinase, the sites on a protein that 
the kinase has phosphorylated must be found. Once found, the phosphorylated sites, or 
phosphopeptides, can be analyzed for patterns. These patterns can then be used to find 
the specificity motif of a kinase.9,11   
A new method, developed by the Schwartz Lab at the University of Connecticut, 
to determine the specificity motif of protein kinases is called ProPeL (Proteomic Peptide 
Library, Figure 2).13  
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Figure 2. A general overview of ProPeL methodology.13,15 The gene for a kinase-of-interest is cloned 
into a bacterial expression vector (i.e. pET45b). Next, transformed E. coli cells are induced to 
overexpress the kinase. To analyze in vivo phosphorylation activity of the kinase, SDS-PAGE is 
performed and the protein gels are stained with Pro-Q® Diamond Phosphoprotein Gel Stain (Life 
Technologies). After confirming kinase activity, the cell lysate containing the kinase and phoshopeptides 
is purified and the proteins are cleaved by trypsin. Titanium Dioxide (TiO2) is implemented to enrich the 
sample for phosphopeptides. Next, the sample is analyzed by liquid chromatography tandem-mass 
spectrometry (LC-MS/MS). A foreground data set is generated by mapping the unique phosphorylated 
tryptic peptides that were identified by LC-MS/MS. Each phosphorylated 15-mer is centered on a 
phosphorylation site (i.e. serine). The data set is inputted into the pLogo software to determine the 
specificity of the kinase-of-interest. This figure is adapted from Chou et al. (2012).13 
 
ProPeL uses bacteria, such as E. coli, to function as an in vivo peptide library for 
thousands of simultaneous phosphorylation reactions carried out by a protein kinase-of-
interest. This strategy begins with the cloning and expression of the kinase of interest in 
E. coli competent cells. E. coli is a convenient model organism for this strategy because 
it does not encode any eukaryotic-like serine/threonine kinases and has very low levels 
of endogenous serine and threonine phosphorylation. This ensures that the majority of 
detected phosphopeptides will be the result of phosphorylation by the expressed 
kinase.13  
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After the kinase is successfully expressed and active, the kinase phosphorylates 
the bacterium’s proteome in vivo, in a manner that is consistent with its sequence 
specificity. After expression, the bacterial proteins are extracted from the cell lysate and 
digested by trypsin.9,12,13 Trypsin is used because the distribution of arginines and 
lysines in the bacterial proteome is such that the resulting peptides are usually 5-15 
amino acids long, which is close to the size needed for standard bottom-up mass 
spectrometry workflows (~7 to 35 amino acids long).9,11  
The digested proteins are purified and enriched for phosphopetides using 
titanium dioxide. Next, liquid chromatography tandem-mass spectrometry (LC-MS/MS) 
is utilized to determine the sequence of the tryptic phosphopeptides.14 Using these 
sequences and pLogo (Probability Logo Generator), the specificity motif for the kinase-
of-interest can be determined.13,15   
pLogo Visualization Tool 
pLogo is a graphical representation of amino acid preferences at each position in 
a sequence motif (Figure 3).15 pLogos illustrate residues proportional to the log-odds of 
their binomial probability with respect to a certain background. For ProPeL pLogos, 
foreground data is obtained by mapping and extending tryptic peptides from LC-MS/MS 
to the E. coli proteome. Background data is generated by aligning all of the unique 
serine-, threonine-, or tyrosine-centered 15-mers in the E. coli proteome.13 These 15 
residue-long peptides are generated by the peptidextender tool, which is a peptide 
extension web tool found at http://schwartzlab.uconn.edu/pepextend/. The pLogo 
generation tool is available for use by the public at http://plogo.uconn.edu/.  
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Figure 3. Visualizing sequence specificity using pLogo.15 Each pLogo image has the following 
characteristics. (1) The height of a residue is proportional to its statistical significance. (2) Over- and 
under-represented residues are portrayed, above and below the x-axis, respectively. (3) The y-axis 
represents the odds of binomial probability on a logarithmic scale. The horizontal lines represent the 
Bonferroni-corrected statistical significance values. (4) Residues are stacked in order of their statistical 
significance; the most significant residues are positioned closest to the x-axis. (5) Fixed motif positions 
are highlighted in gray. This figure is adapted from O’Shea et al. (2013).15  
 
The DYRK Family of Protein Kinases 
General Features. The dual-specificity tyrosine-phosphorylation-regulated kinases 
(DYRKs) are evolutionary conserved enzymes belonging to the CMGC group of protein 
kinases.16,17,18 There are five human DYRKs: DYRK1a, DYRK1b, DYRK2, DYRK3, and 
DYRK4 (Figure 4).19,20 Each DYRK contains a conserved kinase domain that has a 
characteristic structure. Adjacent to the kinase domain is the DYRK homology box, 
which contains variable N- and C-terminal regions. These regions are different in each 
DYRK and may be involved in the regulation of DYRK kinase activity. All DYRKs have 
been found to autophosphorylate on the second tyrosine residue of the YXY motif in the 
activation loop, which is found in the catalytic domain. 
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Figure 4. A phylogenetic tree of human DYRK kinases. This figure is adapted from Yoshida (2008).20 
 
In addition, DYRKs are known to phosphorylate substrates on serine and/or 
threonine residues.17,20,21 It has been suggested that DYRKs autophosphorylate a 
tyrosine residue, but they only phosphorylate their substrates on serine/threonine 
residues.21 Members of the DYRK family are involved in regulating key developmental 
and cellular processes such as neurogenesis, cell growth, the cell cycle, and cellular 
differentiation. Even though DYRK kinases are critical for cell function, the exact 
substrate specificity of each DYRK for serine/threonine phosphorylation has not been 
determined.16,18,25 It has only been suggested that, based on sequence homology in the 
conserved kinase domain, DYRK kinases have a preference for upstream basic 
residues and a proline in the +1 position when phosphorylating substrates.18 This project 
is focused on the type II DYRKs (DYRK2, DYRK3, and DYRK4), however, we do not 
have results for DYRK3 yet.  
DYRK2. DYRK2 is involved in the same cellular and developmental processes as the 
other DYRKs, but its specific cellular functions are only beginning to be discovered.19 
Recent studies have indicated that DYRK2 may have a significant role in tumor 
development and/or progression.20, 21 There is evidence that DYRK2 translocates from 
the cytoplasm to the nucleus following DNA damage. Once in the nucleus, DYRK2 can 
 !
Klaric   11 
!
phosphorylate p53 at Ser46, which induces apoptotic cell death.20 However, even though 
there is significant evidence that DYRK2 is involved in tumor growth and metastasis, the 
substrate specificity for this kinase is still unknown.19,20,21 Discovering the substrate 
specificity of DYRK2 is essential for understanding the functional role of DYRK2 in the 
cell and in human disease.  
DYRK4. The least studied member of the DYRK family is DYRK4. Besides its raw 
sequence, there is hardly any information about its function or its possible target 
substrates.20 It has been suggested that DYRK4 is a testis-specific kinase with a 
possible role in spermatogenesis20,24; however, other researchers have proposed that 
different splice variants of DYRK4 are expressed in tissue-specific patterns.20,24,25 More 
research is needed to determine the functional role and substrate specificity of DYRK4.   
Thesis Project 
To determine the specificity motif and to compare the substrate specificities of DYRK2 
and DYRK4, ProPeL and pLogo were utilized in this project.13,15 The preliminary data 
suggests that the substrate specificities for DYRK2 and DYRK4 are similar to those 
typical of DYRK members. However, there are unique differences between them. 
DYRK2 appears to be able to phosphorylate tyrosine substrates and DYRK4 seems to 
not prefer serine to threonine substrates. With more data, the substrate specificities of 
DYRK2 and DYRK4 will be conclusively determined. 
III. Results 
In vivo Phosphorylation Analysis  
To prove that DYRK2 and DYRK4 were expressed and active in E. coli, total 
protein samples from cell lysates expressing either DYRK2 or DYRK4 were separated 
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by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), and stained 
sequentially with Pro-Q Diamond gel stain (Figure 5A) and GelCode Blue gel stain 
(Figure 5B). Pro-Q Diamond gel stain was used to detect phosphorylated peptides. 
However, Pro-Q Diamond stain also has non-specific activity. GelCode Blue staining, 
which is analogous to Coomassie total protein staining, was used to ensure that 
differences in Pro-Q Diamond staining were not due to gel loading differences. Since 
the negative control (lysate with an empty expression vector) will still contain 
endogenously phosphorylated E. coli proteins, phosphorylation levels related to kinase 
activity must be compared to the negative control.  
The representative gel, containing the samples used for mass spectrometric 
identification of phosphopeptides, is shown in Figure 5. Other gels and expression 
conditions can be found in Supplementary Materials. Compared to the phosphorylation 
levels in E. coli expressing the empty pET45b vector (the negative control sample), the 
DYRK2 sample showed significantly higher levels of phosphorylation. The proteins in 
the DYRK4 sample did not show significantly higher levels of phosphorylation (Figure 
5A). The GelCode Blue Stain shows that there are relatively equal amounts of protein in 
the negative control, DYRK2 sample, and DYRK4 sample (Figure 5B). Therefore, the 
differences in Pro-Q Diamond staining between samples were not the result of gel 
loading differences. !
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Figure 5. Analysis of in vivo phosphorylation. The protein stains utilized in this analysis are Pro-Q® 
Diamond Stain (Life Technologies) and GelCode
TM
 Blue Safe Protein Stain (Life Technologies). Pro-Q 
Diamond gel stain specifically stains phosphoproteins in acrylamide gels. GelCode Blue staining is 
analogous to Coomassie total protein staining. (A and B) Pro-Q® Diamond Phosphoprotein Gel Stain 
(Life Technologies) and GelCode™ Blue Safe Protein Stain (Thermo Fisher Scientific). Legend: Lane 1: 
PeppermintStick
TM
 Phosphoprotein Ladder (Life Technologies), Lane 2: pET45b (Empty Vector Control), 
Lane 3: DYRK2, and Lane 4: DYRK4. 
 
Preliminary DYRK2 Specificity  
After applying the ProPeL methodology to the catalytic domain of DYRK2, endogenous 
phosphorylation sites obtained from the negative control, E. coli expressing the empty 
pET45b vector, were subtracted from the phosphorylation sites obtained from E. coli 
expressing the catalytic domain of DYRK2.13,26,27 Thus, the ProPeL methodology 
resulted in the detection of 77 unique phosphorylation sites in E. coli expressing the 
catalytic domain of DYRK2. Figure 6 shows four DYRK2 pLogos with the ProPeL 
generated E. coli phosphopeptides as the foreground and the E. coli K-12 proteome as 
a background centered on zero residues (Figure 6A), fixed on serine (Figure 6B), 
threonine (Figure 6C), or tyrosine (Figure 6D). Based on the pLogo in Figure 6A, it 
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appears that DYRK2 is capable of phosphorylating serine, threonine, and tyrosine 
substrates. Figures 6B and 6C suggest that for serine and threonine substrates, there 
is a preference for a proline in the +1 position and upstream basic residues. For tyrosine 
substrates, there appears to be a loss in the preference for +1 proline and upstream 
basic residues (Figure 6D). 
 
 !
Klaric   15 
!
!
 
Figure 6. Preliminary DYRK2 substrate specificity. pLogos are constructed from phosphorylation sites 
in E. coli, which were obtained using the ProPeL methodology. (A) DYRK2 pLogo without any fixed 
residues. (B, C, and D) In each pLogo, the central residue is fixed. The fixed residue denotes the 
modification sites for (B) serine-centered, (C) threonine-centered, and (D) tyrosine centered preliminary 
specificity motifs for DYRK2.  
 
Preliminary DYRK4 Specificity  
After applying the ProPeL methodology to the catalytic domain of DYRK4, endogenous 
phosphorylation sites obtained from the negative control, E. coli expressing the empty 
pET45b vector, were subtracted from the phosphorylation sites obtained from E. coli 
expressing the catalytic domain of DYRK4.13,26,27 Thus, the ProPeL methodology 
resulted in the detection of 23 unique phosphorylation sites in E. coli expressing the 
catalytic domain of DYRK4. Figure 7 shows three DYRK4 pLogos with the ProPeL 
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generated E. coli tryptic peptides as the foreground and the E. coli K-12 proteome as a 
background centered on zero residues (Figure 7A), serine (Figure 7B), or threonine 
(Figure 7C). All three DYRK4 plogos in Figure 7 suggest that DYRK4 does not seem to 
have a strong preference for upstream basic residues and/or a proline in the +1 position 
when phosphorylating substrates. The DYRK4 pLogo shown in Figure 7A suggests that 
DYRK4 does not favor serine substrates over threonine substrates, and DYRK4 does 
not appear to be able to phosphorylate tyrosine substrates.  
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Figure 7. Preliminary DYRK4 substrate specificity. pLogos are constructed from phosphorylation sites 
in E. coli, which were obtained using the ProPeL methodology. (A) DYRK4 pLogo without any fixed 
residues. (B and C) In each pLogo, the central residue is fixed. The fixed residue denotes the 
modification sites for (B) serine-centered and (C) threonine-centered preliminary specificity motifs for 
DYRK4.  
 
IV. Discussion 
By expressing the catalytic truncation of DYRK2 and DYRK4 and analyzing the 
unique phosphorylation sites generated by ProPeL, I have been able to obtain 
preliminary data regarding the substrate specificity of these two kinases. Based on the 
literature and our lab’s unpublished data, it has been indicated that the well-classified 
DYRK1a exhibits a strong preference for upstream basic amino acids, as well as a 
proline at the +1 position.28 Therefore, it was exciting to find agreement with our data 
and previous research that for serine or threonine substrates of DYRK2, there appears 
to be a preference a proline in the +1 position. In addition, there seems to be an overall 
upstream basic residue preference, which is expected for members of the DYRK family. 
Interestingly, my data suggests that DYRK2 may exhibit a higher affinity for tyrosine 
substrates than other DYRK members.19 For DYRK2 tyrosine substrates, the preference 
for proline in the +1 position and the presence of upstream basic residues appear to be 
lost.  
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 For DYRK4, the preliminary data suggests that there is a relative importance shift 
in the phosphorylation sites for DYRK4. For other DYRK family members, serine 
substrates are favored over threonine or tyrosine substrates. However, the amount of 
serine and threonine substrates for DYRK4 is the same. In addition, there appears to be 
less preference for upstream basic residues and a proline in the +1 position for DYRK4 
substrates. Unfortunately, compared to DYRK2, fewer phosphopeptides were identified 
for DYRK4. Nevertheless, the preliminary data for DYRK4 is intriguing since it has been 
assumed that for serine/threonine kinases, it is common for there to be a preference for 
serine residues over threonine residues.13,19 It will be very interesting to explore whether 
DYRK4 prefers threonine residues over serine residues.  
 Based on our lab’s unpublished data, in order to be more confident with the 
generated specificity motifs for DYRK2 and DYRK4, at least a few hundred unique 
phosphorylation sites on bacterial proteins will need to be identified for each kinase. 
Currently, only 77 and 23 unique phosphorylation sites have been identified for DYRK2 
and DYRK4, respectively. Since our lab has identified over 4,500 unique sites for 
DYRK1a (*unpublished data*), we have evidence that it is possible to generate a 
sufficient amount of phosphorylation sites, using the ProPeL methodology, to obtain a 
specificity motif with a high degree of statistical significance. In order to obtain an 
adequate amount of unique phosphorylation sites, the ProPeL protocol will need to be 
repeated for DYRK2 and DYRK4.  
Not to mention, minor changes may need to be made to cause these kinases 
work optimally. One of the challenges associated with the ProPeL protocol is that many 
kinases do not activate or express effectively in E. coli. The Supplementary 
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Materials section shows the various external conditions tested on the following protein 
kinases: BGLF4, CDKL5, CLK1, CLK3, DYRK2, DYRK3, and DYRK4. Different growth 
medias, volumes of growth media, growth temperatures, competent E. coli strains, 
induction times, incubation times, and concentrations of IPTG were tested. After testing 
these various growth conditions, DYRK2 and DYRK4 were the only two kinases that 
exhibited any kinase expression and activity (Supplementary Figures 1 and 2). Based 
on these results and previous research in our lab, it is evident that each kinase requires 
specific external conditions in order to fold correctly and carry out 
phosphorylation. Thus, additional expression conditions will need to be tested in order 
to generate specificity motifs for BGLF4, CLK1, CLK3, CDKL5, and DYRK3. 
 Future research involves using the scan-x tool to identify top predicted 
phosphorylation sites on proteins that are known to interact with DYRK2, but which 
presently lack specific site information.29 Mutagenesis will also be implemented to 
identify critical residues involved in DYRK2 and DYRK4 substrate specificity relative to 
other DYRK family members. Using the ProPeL methodology, the Schwartz Lab aspires 
to determine the substrate specificity of the entire DYRK family of kinases, in the near 
future. The lab intends to use the substrate specificities to analyze the structure-function 
relationship of specificity in the CMGC clade of kinases.  
V. Materials and Methods 
ProPeL Methodology13 
Molecular Cloning. The pDNR-Dual vector containing the catalytic domain of the 
DYRK2 (Homo sapiens) gene was purchased from Harvard PlasmID Repository 
(Plasmid ID HsCD00003955). The pDNR-Dual vector containing the catalytic domain of 
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the DYRK4 (Homo sapiens) gene was purchased from Harvard PlasmID Repository 
(Plasmid ID HsCD00003955).30 The catalytic domain of each gene (DYRK2-AA201-550, 
DYRK4-AA81-420) was cloned into the pET45b bacterial expression vector (EMD 
Millipore) through restriction enzyme cloning and ligation. Escherichia coli OverExpress 
C41(DE3) cells (Lucigen) were transformed with the pET45b bacterial expression vector 
containing the gene-of-interest via heat shock treatment. The cells were plated on Luria-
Bertani (LB) plates supplemented with 100µg/mL ampicillin. Colonies were inoculated in 
LB broth supplemented with 100µg/mL ampicillin and grown up overnight in a shaking 
incubator set at 37°C and 250rpm. 1.5mL of overnight culture was diluted into 150mL 
fresh media and grown under the same conditions until OD600 reached 0.6–0.7, at which 
point protein expression was induced with 0.5mM Isopropyl-β-D-1-
thiogalactopyranoside (IPTG) and grown for 4 additional hours. See Supplementary 
Materials for other expression conditions. Cultures were pelleted by centrifugation at 
6000g and 4°C for 15 minutes. Pellets were stored at −80°C until lysis. 
Lysis and Analysis of in vivo Phosphorylation. Cell lysate was prepared according 
to the protocol proposed by Villén and Gygi (2008), with a few modifications.31 Cell 
pellets were resuspended in 0.6mL of lysis buffer (8M urea, 75mM NaCl, 60mM Tris, pH 
8.2) supplemented with Halt Protease Inhibitor Cocktail (EDTA-free) and Halt 
Phosphatase Inhibitor Cocktail (Pierce). The cells were lysed, using a sonicator set at 
15% power. 5 rounds of 15-second pulses, with a 1-minute rest on ice between pulses, 
were sufficient for complete lysis. Crude lysate was clarified by centrifugation at 20,000g 
and 4°C for 30 minutes. Protein concentrations were determined by Bichinchoninic Acid 
(BCA) Assay (Pierce). In vivo phosphorylation by the protein kinase of interest was 
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analyzed through sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE), which separates proteins by size. The gel was first stained with Pro-Q® 
Diamond Phosphoprotein Gel Stain (Life Technologies), which specifically stains 
phosphoproteins in polyacrylamide gels. GelCodeTM Blue Safe Protein Stain (Thermo 
Fisher Scientific) was utilized to evaluate the total protein made from induction. The 
remaining protein lysates were stored at −80°C.  
Protein Reduction, Alkylation, and Tryptic Digestion. Referring to the protocol 
proposed by Villén and Gygi (2008), 10mg of the protein lysate was reduced and 
alkylated. Then, the sample was digested overnight with recombinant trypsin (TrypZean, 
Sigma-Aldrich), at a 1:100 enzyme-to-substrate-ratio.31 Peptides were desalted with 
100mg tC18 SepPak Vac solid-phase extraction cartridges (Waters), snap-frozen in 
liquid nitrogen, and lyophilized until the samples were a white powder.  
Titanium Dioxide Phosphoenrichment. Phosphopeptide enrichment of each sample 
was performed using TiO2 beads (G.L. Sciences), modified from the protocol proposed 
by Kettenbach et al (2011).32 Each sample was desalted with in-house StageTips, 
containing 5 C18 disks.13,31,33 Each sample was dried down by vacuum centrifugation 
and stored at −20°C.  
Mass Spectrometry. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) 
was performed as described by Chou et al. (2012).13 Each sample was resuspended in 
Buffer A (3% Acetonitrile and 0.125% formic acid in water) and injected, using a C18 
nanocapillary column, directly into the inlet of an LTQ Orbitrap XL mass spectrometer 
(Thermo Fisher Scientific). The mass spectrometer was run using a TOP10 method (a 
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mass spectrometric (MS) scan followed by collision MS/MS on the 10 most intense MS 
spectral peaks). Each sample’s spectra were analyzed using SEQUEST.13,34 
pLogo Analysis15  
The foreground data was generated by mapping the tryptic peptides, which were 
mapped by MS/MS) back onto the E. coli protein, and extending the peptides, using the 
peptidextender tool, to create serine-, threonine-, or tyrosine-centered 15-mers. 
Background data was obtained through aligning all of the unique serine-, threonine-, or 
tyrosine-centered 15-mers in the entire E. coli proteome.15 
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VIII.  Supplementary Material  
Supplementary Table 1: Protein Kinases Analyzed in this Project!
Kinase! Plasmid ID Number! Clone Type! Number of Residues! Molecular Weight (kDa)! Activity!
CDKL5! Harvard PlasmID # 
HsCD00022404! Catalytic Domain! 320! 37.01! None!
CLK1! Harvard PlasmID # 
HsCD00005923! Full Length! 484! 57.40! None!
CLK3! Harvard PlasmID # 
HsCD00002779! Catalytic Domain! 357! 41.86! None!
DYRK2! Harvard PlasmID #  
HsCD00003955! Catalytic Domain! 350! 34.45! Expressed!
DYRK3! Harvard PlasmID # 
HsCD00021520! Catalytic Domain! 351! 34.75! None!
DYRK4! Harvard PlasmID # 
HsCD00005301! Catalytic Domain! 351! 32.05! Expressed!
BGLF4! Addgene # 37936! Full-Length! 429! 48.35! None!
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Supplementary Table 2: Kinase Expression Conditions!
 !
 !
Supplementary!
Figure #! Kinases! Cell Strain! Expression Vector! Temperature (°C)! Growth Medium! Volume of Medium 
(mL)! Incubation Time (hr)!
Mid-log 
Induction 
(Yes/No)! IPTG Concentration (mM)! Active Kinase(s)!
1! BGLF4!CDKL5!DYRK2!
DYRK3!
DYRK4! C41 DE3! pET45b! 37! ZYM-5052! 25! 16! No! 0! DYRK2!
2! BGLF4!CDKL5!DYRK2!
DYRK3!
DYRK4! C41 DE3! pET45b! 37! LB! 25! 8! No! 1! DYRK2!
3! BGLF4!CDKL5!DYRK2!
DYRK3!
DYRK4! C41 DE3! pET45b! 37!
LB (2-
Stage 
Induction)! 25! 4 + 4! No! 0.5! DYRK2!
4! BGLF4!CLK1!CLK3!
DYRK3!
DYRK4! C41 DE3! pET45b! 30! LB! 25!
5 (After  Mid-
log 
Induction)! Yes! 0.5! DYRK4!
5 
(Same as Figure 
5)! DYRK2!DYRK4! C41 DE3! pET45b! 30! LB! 150! 4 (After  Mid-log Induction)! Yes! 0.5! DYRK2!DYRK4!
6!
(Lanes 2-5)! DYRK2!DYRK3!DYRK4! Rosetta! pET45b! 37! LB! 25! 16 (After  Mid-log Induction)! Yes! 0.5! DYRK2!
6!
(Lanes 6-9)! DYRK2!DYRK3!DYRK4! Rosetta! pET45b! 20! LB! 25! 16 (After  Mid-log Induction)! Yes! 0.5! DYRK4!
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Supplementary Figure 1 !
Top: Pro-Q® Diamond Phosphoprotein Gel Stain  
Bottom: GelCode™ Blue Safe Protein Stain  
Lane 1:  PeppermintStick™ Phosphoprotein 
Molecular Weight Standards  
Lane 2: pET45b (Empty Vector Control) !
Lane 3: BGLF4 !
Lane 4: CDKL5!
Lane 5: DYRK2!
Lane 6: DYRK3!
Lane 7: DYRK4!
!1!!!!!!2!!!!!!!3!!!!!4!!!!!!5!!!!!!6!!!!!!!7!
!45!kDa!
23.6!kDa!
45!kDa!
23.6!kDa!
116.25!kDa!
66.2!kDa!
!!!18!kDa!
14.4!kDa!
Materials and Methods: Supplementary Figure 1 
Escherichia coli OverExpress C41(DE3) cells (Lucigen) were transformed with the pET45b bacterial expression vector containing 
the gene-of-interest via heat shock treatment. The cells were plated on Luria-Bertani (LB) plates supplemented with 100µg/mL 
ampicillin. Colonies were inoculated in LB broth supplemented with 100µg/mL ampicillin and grown up overnight in a shaking 
incubator set at 37°C and 250rpm. 0.5mL of overnight culture was diluted in 25mL of ZYM-5052 (auto-inducing medium),35  
supplemented with 100µg/mL of ampicillin, at 37°C and 250rpm for 16 hours. The cells were harvested by centrifugation at 
6000g for 15 minutes at 4 °C. Cell lysate was prepared according to the protocol proposed by Villén and Gygi (2008), with a few 
modifications.31 The cell pellets were resuspended in 0.4mL of lysis buffer (8M urea, 75mM NaCl, 60mM Tris, pH 8.2) 
supplemented with Halt Protease Inhibitor Cocktail (EDTA-free) and Halt Phosphatase Inhibitor Cocktail (Pierce). The cells were 
lysed, using a sonicator set at 15% power. 5 rounds of 15-second pulses, with a 1-minute rest on ice between pulses, were 
sufficient for complete lysis. Crude lysate was clarified by centrifugation at 20,000g and 4°C for 30 minutes. Protein concentrations 
were determined by Bichinchoninic Acid (BCA) Assay (Pierce). In vivo phosphorylation by the protein kinase of interest was 
analyzed through sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), which separates proteins by size. The 
gel was first stained with Pro-Q® Diamond Phosphoprotein Gel Stain (Life Technologies), which specifically stains 
phosphoproteins in polyacrylamide gels. GelCodeTM Blue Safe Protein Stain (Thermo Fisher Scientific) was utilized to evaluate the 
total protein made from induction. The remaining protein lysates were stored at −80°C.  
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Supplementary Figure 2 !
Top: Pro-Q® Diamond Phosphoprotein Gel Stain 
Bottom: GelCode™ Blue Safe Protein Stain 
Lane 1:  PeppermintStick™ Phosphoprotein 
Molecular Weight Standards!
Lane 2: pET45b (Empty Vector Control) !
Lane 3: BGLF4 !
Lane 4: CDKL5!
Lane 5: DYRK2!
Lane 6: DYRK3!
Lane 7: DYRK4!
!1!!!!!!2!!!!!3!!!!!4!!!!!5!!!!6!!!!!7!
!45!kDa!
23.6!kDa!
45!kDa!
23.6!kDa!
116.25!kDa!
66.2!kDa!
!!!18!kDa!
14.4!kDa!
Materials and Methods: Supplementary Figure 2 
Escherichia coli OverExpress C41(DE3) cells (Lucigen) were transformed with the pET45b bacterial expression vector containing 
the gene-of-interest via heat shock treatment. The cells were plated on Luria-Bertani (LB) plates supplemented with 100µg/mL 
ampicillin. Colonies were inoculated in LB broth supplemented with 100µg/mL ampicillin and grown up overnight in a shaking 
incubator set at 37°C and 250rpm. 0.5mL of overnight culture was diluted in 25mL of LB broth, supplemented with 100µg/mL of 
ampicillin and 1mM IPTG, at 37°C and 250rpm for 8 hours. The cells were harvested by centrifugation at 6000g for 15 minutes at 
4 °C. Cell lysate was prepared according to the protocol proposed by Villén and Gygi (2008), with a few modifications.31 The cell 
pellets were resuspended in 0.4mL of lysis buffer (8M urea, 75mM NaCl, 60mM Tris, pH 8.2) supplemented with Halt Protease 
Inhibitor Cocktail (EDTA-free) and Halt Phosphatase Inhibitor Cocktail (Pierce). The cells were lysed, using a sonicator set at 15% 
power. 5 rounds of 15-second pulses, with a 1-minute rest on ice between pulses, were sufficient for complete lysis. Crude lysate 
was clarified by centrifugation at 20,000g and 4°C for 30 minutes. Protein concentrations were determined by Bichinchoninic Acid 
(BCA) Assay (Pierce). In vivo phosphorylation by the protein kinase of interest was analyzed through sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE), which separates proteins by size. The gel was first stained with Pro-Q® 
Diamond Phosphoprotein Gel Stain (Life Technologies), which specifically stains phosphoproteins in polyacrylamide gels. 
GelCodeTM Blue Safe Protein Stain (Thermo Fisher Scientific) was utilized to evaluate the total protein made from induction. The 
remaining protein lysates were stored at −80°C.!
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Supplementary Figure 3 
 
Top: Pro-Q® Diamond Phosphoprotein Gel Stain 
Bottom: GelCode™ Blue Safe Protein Stain 
Lane 1:  PeppermintStick™ Phosphoprotein Molecular 
Weight Standards  
Lane 2: pET45b (Empty Vector Control)  
Lane 3: BGLF4  
Lane 4: CDKL5 
Lane 5: DYRK2 
Lane 6: DYRK3 
!1!!!!!2!!!!!3!!!!!4!!!!!5!!!!!6!!!!!7!
!45!kDa!
23.6!kDa!
45!kDa!
23.6!kDa!
116.25!kDa!
66.2!kDa!
Materials and Methods: Supplementary Figure 3 
Escherichia coli OverExpress C41(DE3) cells (Lucigen) were transformed with the pET45b bacterial expression vector containing 
the gene-of-interest via heat shock treatment. The cells were plated on Luria-Bertani (LB) plates supplemented with 100µg/mL 
ampicillin. Colonies were inoculated in LB broth supplemented with 100µg/mL ampicillin and grown up overnight in a shaking 
incubator set at 37°C and 250rpm. 0.5mL of overnight culture was diluted in 25mL of LB broth, supplemented with 100µg/mL of 
ampicillin and 0.5mM IPTG, at 37°C and 250rpm for 4 hours. The cells were harvested by centrifugation at 6000g for 15 minutes 
at 4 °C and washed twice with 10mL of PBS buffer (140 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4·12H2O, 1.8 mM KH2PO4; pH 
7.3), then centrifuged again. The washed cell pellet was resuspended thoroughly in 25 mL of fresh LB broth supplemented with 
100µg/mL ampicillin and 0.5mM IPTG. The culture was grown at 37°C and 250rpm for 4 hours. The cells were harvested by 
centrifugation at 6000g for 15 minutes at 4 °C. Cell lysate was prepared according to the protocol proposed by Villén and Gygi 
(2008), with a few modifications.31 The cell pellets were resuspended in 0.4mL of lysis buffer (8M urea, 75mM NaCl, 60mM Tris, 
pH 8.2) supplemented with Halt Protease Inhibitor Cocktail (EDTA-free) and Halt Phosphatase Inhibitor Cocktail (Pierce). The cells 
were lysed, using a sonicator set at 15% power. 5 rounds of 15-second pulses, with a 1-minute rest on ice between pulses, were 
sufficient for complete lysis. Crude lysate was clarified by centrifugation at 20,000g and 4°C for 30 minutes. Protein concentrations 
were determined by Bichinchoninic Acid (BCA) Assay (Pierce). In vivo phosphorylation by the protein kinase of interest was 
analyzed through sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), which separates proteins by size. The 
gel was first stained with Pro-Q® Diamond Phosphoprotein Gel Stain (Life Technologies), which specifically stains 
phosphoproteins in polyacrylamide gels. GelCodeTM Blue Safe Protein Stain (Thermo Fisher Scientific) was utilized to evaluate the 
total protein made from induction. The remaining protein lysates were stored at −80°C.!
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Supplementary Figure 4 
 
Top: Pro-Q® Diamond Phosphoprotein Gel 
Stain 
Bottom: GelCode™ Blue Safe Protein Stain 
Lane 1: PeppermintStick™ Phosphoprotein 
Molecular Weight Standards 
Lane 2: pET45b (Empty Vector Control)  
Lane 3: BGLF4  
Lane 4: Contaminated Sample 
Lane 5: CLK1 
Lane 6: CLK3 
Lane 7: DYRK3 
Lane 8: DYRK4 
45!kDa!
23.6!kDa!
116.25!kDa!
66.2!kDa!
45!kDa!
23.6!kDa!
14.4!kDa!
18!kDa!
1!!!!!!2!!!!!!3!!!!!!4!!!!!5!!!!!!6!!!!!!7!!!!!!8!
Materials and Methods: Supplementary Figure 4 
Escherichia coli OverExpress C41(DE3) cells (Lucigen) were transformed with the pET45b bacterial expression vector containing 
the gene-of-interest via heat shock treatment. The cells were plated on Luria-Bertani (LB) plates supplemented with 100µg/mL 
ampicillin. Colonies were inoculated in LB broth supplemented with 100µg/mL ampicillin and grown up overnight in a shaking 
incubator set at 37°C and 250rpm. 0.5mL of overnight culture was diluted in 25mL of LB broth, supplemented with 100µg/mL of 
ampicillin, at 30°C and 250rpm. The culture was induced at mid-log stage with 0.5mM IPTG and grown for an additional 5 hours. 
The cells were harvested by centrifugation at 6000g for 15 minutes at 4 °C. Cell lysate was prepared according to the protocol 
proposed by Villén and Gygi (2008), with a few modifications.31 The cell pellets were resuspended in 0.4mL of lysis buffer (8M 
urea, 75mM NaCl, 60mM Tris, pH 8.2) supplemented with Halt Protease Inhibitor Cocktail (EDTA-free) and Halt Phosphatase 
Inhibitor Cocktail (Pierce). The cells were lysed, using a sonicator set at 15% power. 5 rounds of 15-second pulses, with a 1-
minute rest on ice between pulses, were sufficient for complete lysis. Crude lysate was clarified by centrifugation at 20,000g and 
4°C for 30 minutes. Protein concentrations were determined by Bichinchoninic Acid (BCA) Assay (Pierce). In vivo phosphorylation 
by the protein kinase of interest was analyzed through sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), 
which separates proteins by size. The gel was first stained with Pro-Q® Diamond Phosphoprotein Gel Stain (Life Technologies), 
which specifically stains phosphoproteins in polyacrylamide gels. GelCodeTM Blue Safe Protein Stain (Thermo Fisher Scientific) 
was utilized to evaluate the total protein made from induction. The remaining protein lysates were stored at −80°C. 
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Supplementary Figure 5 
 
Top: Pro-Q® Diamond Phosphoprotein Gel Stain  
Bottom: GelCodeTM Blue Safe Protein Stain  
Lane 1: PeppermintStick™ Phosphoprotein Molecular Weight 
Standards  
Lane 2: pET45b (Empty Vector Control)  
Lane 3: DYRK2  
Lane 4: DYRK4 
!1!!!!!!!!2!!!!!!!3!!!!!!!4
!!
45!kDa!
23.6!kDa!
45!kDa!
23.6!kDa!
116.25!kDa!
66.2!kDa!
Materials and Methods: Supplementary Figure 5 
Escherichia coli OverExpress C41(DE3) cells (Lucigen) were transformed with the pET45b bacterial expression vector containing 
the gene-of-interest via heat shock treatment. The cells were plated on Luria-Bertani (LB) plates supplemented with 100µg/mL 
ampicillin. Colonies were inoculated in LB broth supplemented with 100µg/mL ampicillin and grown up overnight in a shaking 
incubator set at 37°C and 250rpm. 1.5mL of overnight culture was diluted in 150mL of LB broth, supplemented with 100µg/mL of 
ampicillin, at 30°C and 250rpm. The culture was induced at mid-log stage with 0.5mM IPTG and grown for an additional 4 hours. 
The cells were harvested by centrifugation at 6000g for 15 minutes at 4 °C. Cell lysate was prepared according to the protocol 
proposed by Villén and Gygi (2008), with a few modifications.31 The cell pellets were resuspended in 0.6mL of lysis buffer (8M 
urea, 75mM NaCl, 60mM Tris, pH 8.2) supplemented with Halt Protease Inhibitor Cocktail (EDTA-free) and Halt Phosphatase 
Inhibitor Cocktail (Pierce). The cells were lysed, using a sonicator set at 15% power. 5 rounds of 15-second pulses, with a 1-
minute rest on ice between pulses, were sufficient for complete lysis. Crude lysate was clarified by centrifugation at 20,000g and 
4°C for 30 minutes. Protein concentrations were determined by Bichinchoninic Acid (BCA) Assay (Pierce). In vivo phosphorylation 
by the protein kinase of interest was analyzed through sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), 
which separates proteins by size. The gel was first stained with Pro-Q® Diamond Phosphoprotein Gel Stain (Life Technologies), 
which specifically stains phosphoproteins in polyacrylamide gels. GelCodeTM Blue Safe Protein Stain (Thermo Fisher Scientific) 
was utilized to evaluate the total protein made from induction. The remaining protein lysates were stored at −80°C. 
!
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Supplementary Figure 6 
 
GelCodeTM Blue Safe Protein Stain  
Lane 1: Precision Plus ProteinTM All Blue 
Standards 
Lane 2: pET45b (Empty Vector Control,37°C) 
Lane 3: DYRK2 (37°C) 
Lane 4: DYRK3 (37°C) 
Lane 5: DYRK4  (37°C) 
Lane 6: pET45b (Empty Vector Control, 20°C) 
Lane 7: DYRK2 (20°C) 
Lane 8: DYRK3 (20°C) 
Lane 9: DYRK4  (20°C) 
1!!!!!!2!!!!!!3!!!!!4!!!!!5!!!!!!6!!!!!7!!!!!8!!!!!!9!!!
!!!!!250!kDa!
!150!kDa!
100!kDa!
75!kDa!
50!kDa!
37!kDa!
25!kDa!
20!kDa!
15!kDa!
10!kDa!
Materials and Methods: Supplementary Figure 6 (Lanes 2-5) 
Escherichia coli RosettaTM competent cells (Novagen) were transformed with the pET45b bacterial expression vector containing 
the gene-of-interest via heat shock treatment. The cells were plated on Luria-Bertani (LB) plates supplemented with 100µg/mL 
ampicillin. Colonies were inoculated in LB broth supplemented with 100µg/mL ampicillin and grown up overnight in a shaking 
incubator set at 37°C and 250rpm. 0.5mL of overnight culture was diluted in 25mL of LB broth, supplemented with 100µg/mL of 
ampicillin, at 37°C and 250rpm. The culture was induced at mid-log stage with 0.5mM IPTG and grown for an additional 16 hours. 
The cells were harvested by centrifugation at 6000g for 15 minutes at 4 °C. Cell lysate was prepared according to the protocol 
proposed by Villén and Gygi (2008), with a few modifications.31 The cell pellets were resuspended in 0.4mL of lysis buffer (8M 
urea, 75mM NaCl, 60mM Tris, pH 8.2) supplemented with Halt Protease Inhibitor Cocktail (EDTA-free) and Halt Phosphatase 
Inhibitor Cocktail (Pierce). The cells were lysed, using a sonicator set at 15% power. 5 rounds of 15-second pulses, with a 1-
minute rest on ice between pulses, were sufficient for complete lysis. Crude lysate was clarified by centrifugation at 20,000g and 
4°C for 30 minutes. Protein concentrations were determined by Bichinchoninic Acid (BCA) Assay (Pierce). In vivo phosphorylation 
by the protein kinase of interest was analyzed through sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), 
which separates proteins by size. The gel was stained with GelCodeTM Blue Safe Protein Stain (Thermo Fisher Scientific), which 
was utilized to evaluate the total protein made from induction. The remaining protein lysates were stored at −80°C. 
  
Materials and Methods: Supplementary Figure 6 (Lanes 6-9) 
Escherichia coli RosettaTM competent cells (Novagen) were transformed with the pET45b bacterial expression vector containing 
the gene-of-interest via heat shock treatment. The cells were plated on Luria-Bertani (LB) plates supplemented with 100µg/mL 
ampicillin. Colonies were inoculated in LB broth supplemented with 100µg/mL ampicillin and grown up overnight in a shaking 
incubator set at 20°C and 250rpm. 0.5mL of overnight culture was diluted in 25mL of LB broth, supplemented with 100µg/mL of 
ampicillin, at 20°C and 250rpm. The culture was induced at mid-log stage with 0.5mM IPTG and grown for an additional 16 hours. 
The cells were harvested by centrifugation at 6000g for 15 minutes at 4 °C. Cell lysate was prepared according to the protocol 
proposed by Villén and Gygi (2008), with a few modifications.31 The cell pellets were resuspended in 0.4mL of lysis buffer (8M 
urea, 75mM NaCl, 60mM Tris, pH 8.2) supplemented with Halt Protease Inhibitor Cocktail (EDTA-free) and Halt Phosphatase 
Inhibitor Cocktail (Pierce). The cells were lysed, using a sonicator set at 15% power. 5 rounds of 15-second pulses, with a 1-
minute rest on ice between pulses, were sufficient for complete lysis. Crude lysate was clarified by centrifugation at 20,000g and 
4°C for 30 minutes. Protein concentrations were determined by Bichinchoninic Acid (BCA) Assay (Pierce). In vivo phosphorylation 
by the protein kinase of interest was analyzed through sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), 
which separates proteins by size. The gel was stained with GelCodeTM Blue Safe Protein Stain (Thermo Fisher Scientific), which 
was utilized to evaluate the total protein made from induction. The remaining protein lysates were stored at −80°C. 
Klaric   33 
